Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia

B Angelin, K S Hershon, J D Brunzell, B Angelin, K S Hershon, J D Brunzell

Abstract

This study was undertaken to characterize bile acid metabolism in hereditary forms of hypertriglyceridemia. Ten hypertriglyceridemic patients (type IV phenotype) with familial combined hyperlipidemia and 7 patients with monogenic familial hypertriglyceridemia (FHTG) were compared with 18 healthy controls; all subjects were males. Pool size, synthesis rate, and fractional catabolic rate of cholic and chenodeoxycholic acids were determined with an isotope dilution technique. Patients with FHTG had synthesis rates of cholic acid, chenodeoxycholic acid, and total bile acids above those seen in normal controls (P less than 0.001); also the fractional catabolic rates of both bile acids were increased (P less than 0.001). In contrast, bile acid kinetic parameters were--with one exception--within normal limits in patients with familial combined hyperlipidemia. The abnormality of bile acid metabolism could also be identified in a normolipidemic individual presumed to carry the gene for FHTG. The postprandial rise of serum bile acids was blunted in FHTG, indicating that the intestinal uptake of bile acids may be deficient in this condition. We conclude that FHTG, but not familial combined hyperlipidemia, is frequently associated with a defective regulation of bile acid synthesis, resulting in abnormally high production rate of bile acids. It is hypothesized that this abnormality is important for the subsequent development of hypertriglyceridemia.

References

    1. J Lipid Res. 1978 Jul;19(5):527-37
    1. Acta Physiol Scand. 1957 Sep 17;40(1):1-9
    1. J Lipid Res. 1978 Nov;19(8):1004-16
    1. J Lipid Res. 1978 Nov;19(8):1017-24
    1. Eur J Clin Invest. 1980 Feb;10(1):17-22
    1. Eur J Clin Invest. 1980 Apr;10(2 Pt 1):161-72
    1. Metabolism. 1981 Sep;30(9):856-68
    1. Arteriosclerosis. 1982 Jan-Feb;2(1):44-57
    1. Metabolism. 1982 May;31(5):438-44
    1. Gastroenterology. 1982 Nov;83(5):1097-101
    1. J Clin Invest. 1982 Oct;70(4):724-31
    1. J Lipid Res. 1983 Feb;24(2):147-55
    1. N Engl J Med. 1985 Aug 1;313(5):277-82
    1. Bull World Health Organ. 1970;43(6):891-915
    1. Arch Intern Med. 1972 Oct;130(4):552-73
    1. Am J Med. 1973 Feb;54(2):148-60
    1. Lancet. 1973 May 5;1(7810):954-9
    1. J Clin Invest. 1973 Jul;52(7):1544-68
    1. Metabolism. 1974 Sep;23(9):863-73
    1. J Clin Invest. 1974 Dec;54(6):1301-11
    1. Eur J Clin Invest. 1974 Dec 5;4(6):405-10
    1. Annu Rev Biochem. 1975;44:233-53
    1. Metabolism. 1976 Mar;25(3):313-20
    1. Adv Intern Med. 1976;21:501-34
    1. Metabolism. 1976 Nov;25(11):1259-68
    1. Ann Intern Med. 1977 Aug;87(2):198-9
    1. J Clin Invest. 1978 Apr;61(4):998-1026
    1. Eur J Clin Invest. 1978 Oct;8(5):283-8

Source: PubMed

3
Abonner